Use App
New
Connect your Agent
Trending
News
Earnings
All
DIA
0.09%
SPY
0.08%
QQQ
0.19%
Trending
AMAT
6.49%
BRUN
15.61%
RCAT
11.44%
AVAV
6.11%
NU
13.06%
UMAC
16.70%
VCX
0.05%
AMPX
7.79%
QMCO
0.32%
YSS
11.38%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
LLYX
news
Exchange:
NYSEArca
·
Updated 09:30 AM EDT
News
all
press releases
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Stocktwits
Full Article
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
Full Article
<
1
>
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile